期刊文献+

小剂量多巴胺对重症患者血清催乳素浓度的影响

Effect of Low-dose Dopamine on Serum Concentrations of Prolactin in Critically Patients
下载PDF
导出
摘要 目的探讨小剂量多巴胺对重症患者血清催乳素浓度的影响,比较不同血清样本催乳素浓度水平的差异.方法取患者基础血清即样本一;常规治疗基础上,经静脉插管使用小剂量多巴胺[2.5μg/(kg·min)]8h后取血清即样本二;停止使用小剂量多巴胺8h后血清即样本三.使用催乳素酶联免疫发光试剂盒分别测定三种血清样本催乳素浓度.结果64%患者基础血清催乳素浓度高于正常水平;使用小剂量多巴胺2.5μg/(kg·min)8h后,血清催乳素浓度均值从744.96mU/L下降至124.9mU/L(降低了83.2%),且有30%的患者表现为低血清催乳素;停用多巴胺8h逆转了此变化趋势,并呈现出82.1%的上调.结论应激可促进催乳素分泌,使血浆催乳素浓度上升.小剂量多巴胺的使用可以显著降低催乳素的血清浓度,导致细胞免疫功能下降,感染的可能性增加,而停用多巴胺可以逆转这种趋势. Objective To investigate the effect of low - dose infusion of dopamine on serum concentrations of prolactin in critically ill patients. Methods Baseline serum was named as sample 1. After dopamine infusion for 8 h, serum sample 2 was obtained and dopamine infusion discontinued for another 8 h. After this time serum sample 3 was obtained. Serum prolactin concentrations of all samples were measured by an immulite prolactin chemiluminescent enzyme immunometric assay system. Results 64% of patients had a supernormal serum prolactin level. Eight hours after commencing the dopamine infusion, the average serum prolactin concentration decreased from 744. 96 to 124. 9 mU/L. This represented an average reduction of 83.2%, with 30% of patients exhibiting a subnormal concentration while receiving dopamine and this reduction was reversed after cessation of dopamine, with an increase of 82. 1%. Conclusions Prolactin secretion was increased in response to physiological stress, while a low - dose dopamine infusion in critically ill patients could markedly reduce serum concentrations of prolactin, which was associated with a reduction in the cellular immune response. This effect was reversible after cessation of dopamine.
作者 凌斌 孙洁
出处 《昆明医学院学报》 2006年第3期106-108,共3页 Journal of Kunming Medical College
关键词 多巴胺 催乳素 血清浓度 Dopamine Prolactin Serum concentration
  • 相关文献

参考文献9

  • 1JUSTE R N,PANIKKAR K,SONI N.The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline[J].Intensive Care Med,1998,24 (6):564-568
  • 2KELLUM J A,DECKER J M.Use of dopamine in acute renal failure:A metaanalysis[J].Crit Care Med,2001,29 (8):1526-1531
  • 3ICHAI C,SOUBIEILE J,CARLES M,et al.Comparison of the renal effect of low to high doses of dopamine and dobutamine in critically ill patients:A single-blind randomized study[J].Crit Care Med,2000,28 (4):921-928
  • 4KADIEVA V S,FRIEDMAN L,MARGOLIUS L P,et al.The effect of dopamine on graft function in patients undergoing renal transplantation[J].Anesth Analg,1993,76 (2):362 -365
  • 5ICHAI C,PASSERON C,CARLES M,et al.Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable,critically ill patients:A single-blind,prospective,controlled study[J].Crit Care Med,2000,28 (5):1329-1335
  • 6赵新生,王鑫.正确评价多巴胺在重症患者中的使用[J].中国医刊,2004,39(8):18-21. 被引量:10
  • 7BELLOMO R,CHAPMAN M,FINFER S,et al.Low -dose dopamine in patients with early renal dysfunction:a placebo-controlled andomized trial.Australian and new Zealand Intensive care society (ANZICS)clinical trials group[J].Lancet,2000,356(9248):2139 -3143
  • 8BERCZI I,NAGY E,MATUSIK R,et al.Pituitary homones regulate C-myc and DNA synthesis in lymphoid tissue[J].Immunol,1996,146:2201-2206
  • 9VAN DEN BERGHE G,DE ZEGHER F,LAUWERS P.Dopamine suppresses pituitary function in infants and children[J].Critical Care Med,1994,22:1747-1753

二级参考文献27

  • 1Clemmesen JO, Galatius S, Skak C, et al. The effect of increasing blood pressure with dopamine on systemic, splanchnic, and lower extremity hemodynamics in patients with acute liver failure[J]. Scand J Gastroenterol, 1999, 34(9):921-927.
  • 2Olson D, Pohlman A, Hall JB. Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance[J]. Am J Respir Crit Care Med, 1996, 154(6 Pt 1):1664-1670.
  • 3Bellomo R, Chapman M, Finfer S,et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled andomized trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group[J]. Lancet, 2000, 356(9248):2139-2143.
  • 4Juste RN, Panikkar K, Soni N. The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline[J]. Intensive Care Med, 1998, 24(6):564-568.
  • 5D'Orio V, el Allaf D, Juchmes J,et al. The use of low doses of dopamine in intensive care medicine[J]. Arch Int Physiol Biochim, 1984, 92(4):S11-S20.
  • 6Chamorro C, Romera MA, Martinez-Melgar JL, et al. Dopamine dose and renal damage[J]. Lancet, 2001, 357(9269):1707-1708.
  • 7Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004, 32(3):858-873.
  • 8Devins SS, Miller A, Herndon BL,et al. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients[J]. Crit Care Med, 1992, 20(12):1644-1649.
  • 9Van den Berghe G, de Zegher F, Lauwers P,et al. Growth hormone secretion in critical illness: effect of dopamine[J]. J Clin Endocrinol Metab, 1994, 79(4):1141-1146.
  • 10Van den Berghe G, de Zegher F, Lauwers P. Dopamine suppresses pituitary function in infants and children[J]. Crit Care Med, 1994, 22(11):1747-1753.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部